| Literature DB >> 25115230 |
Çiğdem Çelik1, Neslihan Arhun, Kivanc Yamanel.
Abstract
OBJECTIVES: The aim of this study was to evaluate the clinical performance of a nanohybrid and a microhybrid composite in class I and II restorations after 3 years. SUBJECTS AND METHODS: A total of 82 class I and class II restorations were performed in 31 patients (10 males and 21 females) using Grandio and QuiXfil with self-etch adhesives (Futurabond and Xeno III). The restorations were clinically evaluated by 2 operators 1 week after placement (baseline) and at 6 months and 1, 2, and 3 years using modified United States Public Health Service (USPHS) criteria. At the 3-year follow-up, 62 class I and class II cavities were reevaluated in 23 patients (7 males and 16 females). Statistical analysis was performed using Pearson's χ(2) and Fisher's exact tests (p < 0.05).Entities:
Mesh:
Substances:
Year: 2014 PMID: 25115230 PMCID: PMC5586919 DOI: 10.1159/000364874
Source DB: PubMed Journal: Med Princ Pract ISSN: 1011-7571 Impact factor: 1.927
Material descriptions, batch numbers, and manufacturers of the materials used in this study
| Material description | Material | Chemical composition | Manufacturer | Lot No. |
|---|---|---|---|---|
| Dentin-bonding agent: light-curing self-etch bond reinforced with nanofillers | Futurabond NR | Liquid A: methacryl phosphorus acid ester and carbonic acid-modified methacrylic ester | ||
| Liquid B: water, ethanol, silicon pH = 1.4 | Voco GmbH, Germany | 610456 | ||
| Dentin-bonding agent: single-step self-etch fluoride-releasing adhesive | Xeno III | Liquid A: HEMA, purified water, ethanol urethane dimethacrylate resin, BHT, highly dispersed silicon dioxide | ||
| Liquid B: phosphoric acid-modified polymethacrylate resin, monofluorophosphazene-modified methacrylate resin, UDMA, BHT, camphorquinone, ethyl-4-dimethylaminobenzoate pH = 1.4 | Dentsply Caulk, Germany | 0505001099 | ||
| Resin composite: universal light-curing nanohybrid resin composite | Grandio | 87s% w/w (71s% volume) inorganic nanohybrid filler, BisGMA, UDMA, TEGDMA | Voco GmbH, Germany | 620492 |
| Resin composite: posterior resin composite | QuiXfil | 86s% by weight (66s% volume) filler load UDMA, TEGDMA, di- and trimethacrylate resins, carboxylic acid-modified dimethacrylate resin, BHT, UV stabilizer, camphorquinone, ethyl-4-dimethylaminobenzoate, silinated strontium aluminum sodium fluoride phosphate silicate glass | Dentsply Caulk, Germany | 0607001089 |
BHT = Butylated hydroxy toluene; BisGMA = bisphenol-A-diglycidylether dimethacrylate; HEMA = 2-hydroxyethyl methacrylate; TEGDMA = triet-hylenglycoldimethacryate; UDMA = urethane dimethacrylate.
Distribution of materials and tooth locations of the restorations at baseline
| Restorative materials | Maxillary arch | Mandibular arch | Total | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| premolar | molar | premolar | molar | ||||||||||||
| class I | class II | class I | class II | class I | class II | class I | class II | ||||||||
| Grandio | – | 11 | 8 | 5 | – | 10 | 3 | 4 | 41 | ||||||
| QuiXfil | – | 14 | 6 | 3 | – | 7 | 9 | 2 | 41 | ||||||
| Subtotal | – | 25 | 14 | 8 | – | 17 | 12 | 6 | |||||||
| Total | 47 | 35 | 82 | ||||||||||||
Modified USPHS evaluation criteria
| Retention | Alfa: no loss of restorative material |
| Color match | Alfa: match with the tooth |
| Marginal discoloration | Alfa: no discoloration |
| Marginal adaptation | Alfa: closely adapted, no visible crevice |
| Secondary caries | Alfa: no caries present |
| Surface texture | Alfa: enamel-like surface |
| Anatomic form | Alfa: continuous |
| Postoperative sensitivity | Alfa: not present |
Distribution of materials and tooth locations of the restorations after 3 years
| Restorative materials | Maxillar arch | Mandibular arch | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
| premolar | molar | premolar | molar | ||||||
| class I | class II | class I | class II | class I | class II | class I | class II | ||
| Grandio | – | 10 | 8 | 2 | – | 5 | 3 | 3 | 31 |
| QuiXfil | – | 12 | 5 | 2 | – | 3 | 9 | 0 | 31 |
| Subtotal | – | 22 | 13 | 4 | – | 8 | 12 | 3 | |
| Total | 39 | 23 | 62 | ||||||
Summary of the clinical findings of the modified USPHS criteria at the end of 3 years
| Baseline | 6 months | 1 year | 2 years | 3 years | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Grandio (n = 41) | QuiXfil (n = 41) | Grandio (n = 41) | QuiXfil (n = 41) | Grandio (n = 41) | QuiXfil (n = 41) | Grandio (n = 35) | QuiXfil (n = 35) | Grandi (n = 31) | QuiXfil (n = 31) | |
| Retention | ||||||||||
| A 41 | 41 | 41 | 41 | 41 | 41 | 34 | 35 | 31 | 31 | |
| C 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
| Color match | ||||||||||
| A 41 | 41 | 41 | 41 | 39 | 41 | 32 | 35 | 28 | 31 | |
| B 0 | 0 | 0 | 0 | 2 | 0 | 3 | 0 | 3 | 0 | |
| C 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Marginal discoloration | ||||||||||
| A 41 | 41 | 41 | 41 | 41 | 41 | 35 | 33 | 30 | 28 | |
| B 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 3 | |
| C 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Marginal adaptation | ||||||||||
| A 41 | 41 | 41 | 41 | 37 | 40 | 30 | 31 | 26 | 27 | |
| B 0 | 0 | 0 | 0 | 4 | 1 | 5 | 4 | 5 | 4 | |
| C 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Secondary caries | ||||||||||
| A 41 | 41 | 41 | 41 | 41 | 39 | 35 | 35 | 31 | 30 | |
| C 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | |
| Surface texture | ||||||||||
| A 41 | 41 | 41 | 41 | 40 | 41 | 26 | 34 | 21 | 30 | |
| B 0 | 0 | 0 | 0 | 1 | 0 | 9 | 1 | 10 | 1 | |
| C 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Anatomic form | ||||||||||
| A 41 | 41 | 41 | 41 | 41 | 41 | 35 | 35 | 31 | 30 | |
| B 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
| C 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Postoperative sensitivity | ||||||||||
| A 41 | 41 | 41 | 41 | 41 | 41 | 35 | 35 | 31 | 31 | |
| B 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| C 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |